O Van Cutsem

Clinique Saint-Joseph — Belgium

Medicine · Health Sciences

14h-index1.2kcitations54works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(35), Lung Cancer Research Studies(27), Lung Cancer Diagnosis and Treatment(15), Neuroendocrine Tumor Research Advances(10), Cancer therapeutics and mechanisms(8)

Publications54 total

Brachial metastatic plexopathy as the inaugural manifestation of lung cancer: multimodality imaging
BJR|case reports·2016· 2 citedOpen Access
CT halo sign and crazy paving pattern due to lung metastases hemorrhage after sunitinib therapy
Diagnostic and Interventional Imaging·2016· 2 cited
Pancreaticobronchial Fistula Diagnosed by MDCT
Journal of the Belgian Society of Radiology·2015Open Access
A phase III trial comparing concomitant radiochemotherapy (RT-CT) with cisplatin (P) and docetaxel (D) as induction versus consolidation in patients with locally advanced unresectable non-small cell lung cancer (NSCLC). An ELCWP study
2015
Bronchial lipoma : an unusual cause of pleural empyema
Journal of the Belgian Society of Radiology·2015· 6 citedOpen Access
Validation and comparison of several published prognostic systems for patients with small cell lung cancer
European Respiratory Journal·2011· 7 citedOpen Access
Chemotherapy improves low performance status lung cancer patients
European Respiratory Journal·2007· 28 citedOpen Access
How much can patients, with low Karnofsky performance status and advanced non-small cell lung cancer, benefit from cisplatin-based chemotherapy? A retrospective analysis of a phase III randomised trial
Journal of Clinical Oncology·2007
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party
British Journal of Cancer·2007· 10 citedOpen Access
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer
Annals of Oncology·2007· 20 citedOpen Access
498 Chimiothérapie conventionnelle versus traitement séquentiel du cancer bronchique non à petites cellules (CBNPC) avancé : une étude randomisée de phase III
Revue des Maladies Respiratoires·2007
A phase III randomised trial comparing sequential to standard chemotherapy in advanced non-small cell lung cancer (NSCLC)
Journal of Clinical Oncology·2006· 6 cited
Second-line paclitaxel for primary or secondary failure in non-small cell lung cancer (NSCLC) initially treated with cisplatin-gemcitabine-ifosfamide (GIP) A preliminary analysis of a study by the ELCWP
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)·2006
Sequential versus standard chemotherapy in advanced non-small cell lung cancer: a phase III randomised trial
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)·2006
A randomised phase III trial by the ELCWP comparing sequential administration of cisplatin-based chemotherapy followed by a taxan and a cisplatin-based chemotherapy with the use of taxan as salvage treatment
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)·2006
European Lung Cancer Working Party Clinical Practice Guidelines. Non-Small Cell Lung Cancer: III. Metastatic disease
Hospital chronicles/Hospital Chronicles·2006· 7 citedOpen Access
P-194 A feasibility study preparing to a phase III randomised trialcomparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer. A trial conducted by the European Lung Cancer Working Party (ELCWP)
Lung Cancer·2005
Concurrent radiochemotherapy (RT-CT) with cisplatin (C), gemcitabine (G) and vinorelbine (V) in patients with locally advanced non-small cell lung cancer (NSCLC): preliminary toxicity results within a randomized trial of European Lung Cancer Working Party (ELCWP)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)·2004
A phase II randomised trial comparing the cisplatin–etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer
Annals of Oncology·2002· 19 citedOpen Access
A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy
Lung Cancer·2002· 29 cited
page 1 of 3Next →

Frequent Co-authors

Marianne Paesmans(30), Jean‐Paul Sculier(28), G. Bureau(25), P. Mommen(25), Jean Klášterský(24), V. Giner(23), J Thiriaux(22), M.C. Berchier(20), Vincent Ninane(18), P Libert(15), J. Lecomte(15), Thierry Berghmans(14), Anna Efremidis(13), G Dabouis(12), M Paesmans(12), R Sergysels(11), Arnaud Scherpereel(10), J.J. Lafitte(9), J.P. Sculier(9), P. Recloux(8)